Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

LYELLYEL
Showing 8 of 20 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in LYELL IMMUNOPHARMA INC

GEODE CAPITAL MANAGEMENT, LLC holds 166,980 shares of LYEL (LYELL IMMUNOPHARMA INC), worth $3.4M as of 2026-Q1. The position was increased (+2.4% shares). LYEL represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$3.4M

Current Shares

166,980

Total Value Change

-$2.5M

Total Shares Change

-3.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
166,980
+2.4%
$3.4M0.0%$23.33
27
2025-Q4
Increased
162,997
+25.1%
$5M0.0%$31.59
33
2025-Q3
Increased
130,257
+26.1%
$2.1M0.0%$14.97
32
2025-Q2
Decreased
103,270
-97.7%
$913,2610.0%$8.94
0
2025-Q1
Increased
4.4M
+6.3%
$2.4M0.0%$10.82
28
2024-Q4
Increased
4.1M
+2.9%
$2.6M0.0%$12.42
27
2024-Q3
Increased
4M
+0.2%
$5.5M0.0%$30.20
27
2024-Q2
Decreased
4M
-0.1%
$5.8M0.0%$29.00
0

Other major holders of LYEL: HHLR ADVISORS, LTD., BlackRock Finance, Inc., PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used